NEW YORK (360Dx) – Techlab announced on Tuesday that it has received US Food and Drug Administration 510(k) clearance for its rapid Entamoeba histolytica infection test.

E. histolyticais a protozoan parasite that can cause the intestinal disease amoebiasis. According to Techlab, the parasite is morphologically identical to the non-pathogenic species Entamoeba dispar, making diagnosis of infection difficult.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sponsored by

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.